Search - tctmd.com

Displaying 1 - 14 of 14

Sort: Relevancy | Date

Presentation TCTAP 2018

OPTIMA Trial: P2Y12 Dose Adjustment for East-Asian ACS Patients

Presenter: Duk-Woo Park

April 28, 2018

Presentation TCTAP 2018

Distal Left Main Bifurcation PCI: Concept is More Important

Presenter: Jung-Min Ahn

April 28, 2018

Presentation TCTAP 2018

DECISION-CTO: Updated QOL and Long-Term Outcomes

Presenter: Seung-Whan Lee

April 28, 2018

Presentation TCTAP 2013

ESSENCE-DIABETES II Trial

Presenter: Gyung-Min Park

April 25, 2013

Presentation TCTAP 2012

Why FFR and Why Not FFR in Bifurcation Lesions

Presenter: Bon-Kwon Koo

April 26, 2012

Presentation TCTAP 2012

Update of Dedicated Bifurcation Stents

Presenter: Martin B. Leon

April 26, 2012

Presentation TCTAP 2012

The EXCEL Trial Design, Status, and Timelines

Presenter: Gregg W. Stone

April 26, 2012

Presentation TCTAP 2012

Risk Scores for Appropriate Left Main Revascularization

Presenter: Corrado Tamburino

April 26, 2012

Presentation TCTAP 2012

My Top 10 Rules in Non-LM Bifurcation Stenting

Presenter: Antonio Colombo

April 26, 2012

Presentation TCTAP 2012

Indian TUXEDO Trial In Medically Treated Diabetics

Presenter: Upendra Kaul

April 26, 2012

Presentation TCTAP 2012

Evidence-Based Pharmacotherapy Recommendations for PCI, NSTEMI, and STEMI:

Presenter: Gregg W. Stone

April 26, 2012

Presentation TCTAP 2012

Everolimus-Eluting Stent Implantation for Unprotected Left Main Stenosis:

Presenter: Young-Hak Kim

April 26, 2012

Presentation TCTAP 2012

CROSS and PERFECT Trials: Preliminary Results

Presenter: Young-Hak Kim

April 26, 2012

Presentation TCTAP 2012

4-year Outcomes of SYNTAX Left Main

Presenter: Pawel E. Buszman

April 26, 2012

Advertisement

OPTIMA Trial: P2Y12 Dose Adjustment for East-Asian ACS Patients

Distal Left Main Bifurcation PCI: Concept is More Important

DECISION-CTO: Updated QOL and Long-Term Outcomes

ESSENCE-DIABETES II Trial

Why FFR and Why Not FFR in Bifurcation Lesions

Update of Dedicated Bifurcation Stents

The EXCEL Trial Design, Status, and Timelines

Risk Scores for Appropriate Left Main Revascularization

My Top 10 Rules in Non-LM Bifurcation Stenting

Indian TUXEDO Trial In Medically Treated Diabetics

Evidence-Based Pharmacotherapy Recommendations for PCI, NSTEMI, and STEMI:

Everolimus-Eluting Stent Implantation for Unprotected Left Main Stenosis:

CROSS and PERFECT Trials: Preliminary Results

4-year Outcomes of SYNTAX Left Main

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content